Ken Griffin Artivion, Inc. Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$19.62 - $25.65 $237,402 - $310,365	-12,100 Reduced 67.22%	5,900 $151,000
Q1 2024 May 15, 2024	BUY	$16.7 - $21.63 $143,620 - $186,018	8,600 Added 91.49%	18,000 $380,000
Q4 2023 Feb 14, 2024	SELL	$12.33 - $18.83 $22,194 - $33,894	-1,800 Reduced 16.07%	9,400 $168,000
Q3 2023 Nov 14, 2023	SELL	$14.82 - $17.52 $125,970 - $148,920	-8,500 Reduced 43.15%	11,200 $169,000
Q2 2023 Aug 14, 2023	BUY	$12.78 - $17.23 $58,788 - $79,258	4,600 Added 30.46%	19,700 $338,000
Q1 2023 May 15, 2023	BUY	$11.74 - $14.12 $109,182 - $131,316	9,300 Added 160.34%	15,100 $197,000
Q4 2022 Feb 14, 2023	SELL	$10.01 - $13.9 $118,118 - $164,020	-11,800 Reduced 67.05%	5,800 $70,000
Q3 2022 Nov 14, 2022	BUY	$13.31 - $23.25 $234,256 - $409,200	17,600 New	17,600 $244,000

166

35.4M

21K

6.8K

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.02B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.